Modular Medical Files Series Of Software Enhancements To Its PivotTM Insulin Delivery System To FDA

Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ: MODD ), a leader in innovative, patient-centric insulin delivery technology, today announced submission to the U.S. Food & Drug Administration (FDA) of a series of software enhancements to its PivotTM insulin delivery system, providing users with more customization options and user-interface (UI) improvements, as well as other software upgrades.